Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:31
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:29
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:27
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:26
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:25
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:22
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:21
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:20
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:19
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:18
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:15
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 16:14
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:37
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by mphilemon@resea... on Fri, 05/25/2012 - 15:18
Select Publications
Bachelot T et al. TAMRAD: A GINECO randomized Phase II trial of everolimus in combination with tamoxifen versus tamoxifen alone in patients (pts) with hormone-receptor positive, HER2 negative metastatic breast cancer (MBC) with prior exposure to aromatase inhibitors (AI). San Antonio Breast Cancer Symposium 2010;Abstract S1-6.
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by mphilemon@resea... on Fri, 05/25/2012 - 15:06
TARGET AUDIENCE
This activity is intended for medical oncologists and other healthcare providers involved in the treatment of breast cancer.
OVERVIEW OF ACTIVITY